FGF23 regulates renal sodium handling and blood pressure

EMBO Molecular Medicine

Volumn 6, Issue 6, 2014, Pages 744-759

  Andrukhova, Olena ^a   Slavic, Svetlana ^a   Smorodchenko, Alina ^a   Zeitz, Ute ^a   Shalhoub, Victoria ^b   Lanske, Beate ^c   Pohl, Elena E ^a   Erben, Reinhold G ^a  

^a UNIVERSITY OF VETERINARY MEDICINE   (Austria)

^b AMGEN INC   (United States)

^c HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Aldosterone; Blood pressure; Fibroblast growth factor 23; Heart hypertrophy; Sodium homeostasis

Indexed keywords

CHLOROTHIAZIDE; FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR RECEPTOR; ION CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN KINASE WNK4; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SODIUM; ANTIHYPERTENSIVE AGENT; BETA GLUCURONIDASE; FIBROBLAST GROWTH FACTOR; KLOTHO PROTEIN; RECOMBINANT PROTEIN; SODIUM CHLORIDE COTRANSPORTER; THIAZIDE DIURETIC AGENT;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CELL MEMBRANE; CONTROLLED STUDY; FOOD INTAKE; HEART HYPERTROPHY; HISTOPATHOLOGY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INTRACELLULAR SIGNALING; KIDNEY CORTEX; KIDNEY DISTAL TUBULE; KIDNEY PROXIMAL TUBULE; MOUSE; NEPHRON; NONHUMAN; PRIORITY JOURNAL; SODIUM ABSORPTION; SODIUM INTAKE; SODIUM RESTRICTION; SODIUM URINE LEVEL; WESTERN BLOTTING; WILD TYPE; ANIMAL; C57BL MOUSE; CARDIOMEGALY; GENE DELETION; GENETICS; HUMAN; KIDNEY; MALE; METABOLISM; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOMEGALY; CHLOROTHIAZIDE; FIBROBLAST GROWTH FACTORS; GENE DELETION; GLUCURONIDASE; HUMANS; HYPERTENSION; KIDNEY; MALE; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SODIUM; SODIUM CHLORIDE SYMPORTER INHIBITORS; SOLUTE CARRIER FAMILY 12, MEMBER 3; UP-REGULATION;

EID: 84901745038     PISSN: 17574676     EISSN: 17574684     Source Type: Journal    
DOI: 10.1002/emmm.201303716     Document Type: Article

References (56)

1. Andrukhova O, Zeitz U, Goetz R, Mohammadi M, Lanske B, Erben RG (2012) FGF23 acts directly on renal proximal tubules to induce phosphaturia through activation of the ERK1/2-SGK1 signaling pathway. Bone 51: 621-628
2. Andrukhova O, Smorodchenko A, Egerbacher M, Streicher C, Zeitz U, Goetz R, Shalhoub V, Mohammadi M, Pohl EE, Lanske B et al (2014) FGF23 promotes renal calcium reabsorption through the TRPV5 channel. EMBO J 33: 229-246
3. Anour R, Andrukhova O, Ritter E, Zeitz U, Erben RG (2012) Klotho lacks a vitamin D independent physiological role in glucose homeostasis, bone turnover, and steady-state PTH secretion in vivo. PLoS ONE 7: e31376
4. Barron WM, Stamoutsos BA, Lindheimer MD (1984) Role of volume in the regulation of vasopressin secretion during pregnancy in the rat. J Clin Invest 73: 923-932
5. Barros NM, Hoac B, Neves RL, Addison WN, Assis DM, Murshed M, Carmona AK, McKee MD (2013) Proteolytic processing of osteopontin by PHEX and accumulation of osteopontin fragments in Hyp mouse bone, the murine model of X-linked hypophosphatemia. J Bone Miner Res 28: 688-699
6. Cai H, Cebotaru V, Wang YH, Zhang XM, Cebotaru L, Guggino SE, Guggino WB (2006) WNK4 kinase regulates surface expression of the human sodium chloride cotransporter in mammalian cells. Kidney Int 69: 2162-2170
7. - cotransporter by angiotensin II is a WNK4-dependent process. Proc Natl Acad Sci USA 109: 7929-7934
8. Chen SY, Bhargava A, Mastroberardino L, Meijer OC, Wang J, Buse P, Firestone GL, Verrey F, Pearce D (1999) Epithelial sodium channel regulated by aldosterone-induced protein sgk. Proc Natl Acad Sci USA 96: 2514-2519
9. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 167: 879-885
10. Erben RG, Soegiarto DW, Weber K, Zeitz U, Lieberherr M, Gniadecki R, Möller G, Adamski J, Balling R (2002) Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol Endocrinol 16: 1524-1537
11. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutierrez OM, Aguillon-Prada R, Lincoln J, Hare JM et al (2011) FGF23 induces left ventricular hypertrophy. J Clin Invest 121: 4393-4408
12. Fischer SS, Kempe DS, Leibrock CB, Rexhepaj R, Siraskar B, Boini KM, Ackermann TF, Foller M, Hocher B, Rosenblatt KP et al (2010) Hyperaldosteronism in Klotho-deficient mice. Am J Physiol Renal Physiol 299: F1171-F1177
13. Flores SY, Debonneville C, Staub O (2003) The role of Nedd4/Nedd4-like dependant ubiquitylation in epithelial transport processes. Pflugers Arch 446: 334-338
14. Harootunian AT, Kao JP, Eckert BK, Tsien RY (1989) Fluorescence ratio imaging of cytosolic free Na+ in individual fibroblasts and lymphocytes. J Biol Chem 264: 19458-19467
15. Hesse M, Frohlich LF, Zeitz U, Lanske B, Erben RG (2007) Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice. Matrix Biol 26: 75-84
16. Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, Kuro-o M et al (2010) Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24: 3438-3450
17. Juppner H, Wolf M, Salusky IB (2010) FGF-23: More than a regulator of renal phosphate handling? J Bone Miner Res 25: 2091-2097
18. Kahle KT, Wilson FH, Leng Q, Lalioti MD, O'Connell AD, Dong K, Rapson AK, MacGregor GG, Giebisch G, Hebert SC et al (2003) WNK4 regulates the balance between renal NaCl reabsorption and K+ secretion. Nat Genet 35: 372-376
19. Ko B, Joshi LM, Cooke LL, Vazquez N, Musch MW, Hebert SC, Gamba G, Hoover RS (2007) Phorbol ester stimulation of RasGRP1 regulates the sodium-chloride cotransporter by a PKC-independent pathway. Proc Natl Acad Sci USA 104: 20120-20125
20. Ko B, Kamsteeg EJ, Cooke LL, Moddes LN, Deen PM, Hoover RS (2010) RasGRP1 stimulation enhances ubiquitination and endocytosis of the sodium-chloride cotransporter. Am J Physiol Renal Physiol 299: F300-F309
21. Ko B, Mistry AC, Hanson L, Mallick R, Wynne BM, Thai TL, Bailey JL, Klein JD, Hoover RS (2013) Aldosterone acutely stimulates NCC activity via a SPAK-mediated pathway. Am J Physiol Renal Physiol 305: F645-F652
22. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E et al (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390: 45-51
23. Lang F, Artunc F, Vallon V (2009) The physiological impact of the serum and glucocorticoid-inducible kinase SGK1. Curr Opin Nephrol Hypertens 18: 439-448
24. Lattanzio MR, Weir MR (2010) Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease? Curr Hypertens Rep 12: 369-377
25. Lee HB, Blaufox MD (1985) Blood volume in the rat. J Nucl Med 26: 72-76
26. Lee IH, Campbell CR, Song SH, Day ML, Kumar S, Cook DI, Dinudom A (2009) The activity of the epithelial sodium channels is regulated by caveolin-1 via a Nedd4-2-dependent mechanism. J Biol Chem 284: 12663-12669
27. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB (1998) Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139: 4391-4396
28. Liu S, Guo R, Simpson LG, Xiao ZS, Burnham CE, Quarles LD (2003) Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX. J Biol Chem 278: 37419-37426
29. van der Lubbe N, Lim CH, Meima ME, van VR, Rosenbaek LL, Mutig K, Danser AH, Fenton RA, Zietse R, Hoorn EJ (2012) Aldosterone does not require angiotensin II to activate NCC through a WNK4-SPAK-dependent pathway. Pflugers Arch 463: 853-863.
30. Martin A, David V, Quarles LD (2012) Regulation and function of the FGF23/klotho endocrine pathways. Physiol Rev 92: 131-155
31. Masilamani S, Kim GH, Mitchell C, Wade JB, Knepper MA (1999) Aldosterone-mediated regulation of ENaC alpha, beta, and gamma subunit proteins in rat kidney. J Clin Invest 104: R19-R23
32. May A, Puoti A, Gaeggeler HP, Horisberger JD, Rossier BC (1997) Early effect of aldosterone on the rate of synthesis of the epithelial sodium channel alpha subunit in A6 renal cells. J Am Soc Nephrol 8: 1813-1822
33. Monroy A, Plata C, Hebert SC, Gamba G (2000) Characterization of the thiazide-sensitive Na(+)-Cl(-) cotransporter: a new model for ions and diuretics interaction. Am J Physiol Renal Physiol 279: F161-F169
34. Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D (2004) Bartter's and Gitelman's syndromes: from gene to clinic. Nephron Physiol 96: 65-78
35. Nehgme R, Fahey JT, Smith C, Carpenter TO (1997) Cardiovascular abnormalities in patients with X-linked hypophosphatemia. J Clin Endocrinol Metab 82: 2450-2454
36. Nesterov V, Dahlmann A, Krueger B, Bertog M, Loffing J, Korbmacher C (2012) Aldosterone-dependent and -independent regulation of the epithelial sodium channel (ENaC) in mouse distal nephron. Am J Physiol Renal Physiol 303: F1289-F1299
37. Ohta A, Rai T, Yui N, Chiga M, Yang SS, Lin SH, Sohara E, Sasaki S, Uchida S (2009) Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure. Hum Mol Genet 18: 3978-3986
38. - cotransporter is activated and phosphorylated at the amino-terminal domain upon intracellular chloride depletion. J Biol Chem 281: 28755-28763
39. Ring AM, Leng Q, Rinehart J, Wilson FH, Kahle KT, Hebert SC, Lifton RP (2007) An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis. Proc Natl Acad Sci USA 104: 4025-4029
40. Rozansky DJ, Cornwall T, Subramanya AR, Rogers S, Yang YF, David LL, Zhu X, Yang CL, Ellison DH (2009) Aldosterone mediates activation of the thiazide-sensitive Na-Cl cotransporter through an SGK1 and WNK4 signaling pathway. J Clin Invest 119: 2601-2612
41. Saito H, Maeda A, Ohtomo S, Hirata M, Kusano K, Kato S, Ogata E, Segawa H, Miyamoto K, Fukushima N (2005) Circulating FGF-23 is regulated by 1alpha, 25-dihydroxyvitamin D3 and phosphorus in vivo. J Biol Chem 280: 2543-2549
42. Scialla JJ, Lau WL, Reilly MP, Isakova T, Yang HY, Crouthamel MH, Chavkin NW, Rahman M, Wahl P, Amaral AP et al (2013) Fibroblast growth factor 23 is not associated with and does not induce arterial calcification. Kidney Int 83: 1159-1168
43. Sharma S, McFann K, Chonchol M, de Boer IH, Kendrick J (2013) Association between dietary sodium and potassium intake with chronic kidney disease in US adults: a cross-sectional study. Am J Nephrol 37: 526-533
44. Shimada T, Mizutani S, Muto T, Yoneya T, Hino R, Takeda S, Takeuchi Y, Fujita T, Fukumoto S, Yamashita T (2001) Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia. Proc Natl Acad Sci USA 98: 6500-6505
45. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T (2004a) FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19: 429-435
46. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T (2004b) Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113: 561-568
47. Shimada T, Yamazaki Y, Takahashi M, Hasegawa H, Urakawa I, Oshima T, Ono K, Kakitani M, Tomizuka K, Fujita T et al (2005) Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism. Am J Physiol Renal Physiol 289: F1088-F1095
48. Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Juppner H, Lanske B (2004) Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23: 421-432
49. Streicher C, Zeitz U, Andrukhova O, Rupprecht A, Pohl E, Larsson TE, Windisch W, Lanske B, Erben RG (2012) Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor. Endocrinology 153: 1795-1805
50. The ADHR Consortium (2000) Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23. Nat Genet 26: 345-348
51. Tsujikawa H, Kurotaki Y, Fujimori T, Fukuda K, Nabeshima Y (2003) Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 17: 2393-2403
52. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T (2006) Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444: 770-774
53. Weber TJ, Liu S, Indridason OS, Quarles LD (2003) Serum FGF23 levels in normal and disordered phosphorus homeostasis. J Bone Miner Res 18: 1227-1234
54. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I, Gunel M, Milford DV, Lipkin GW, Achard JM et al (2001) Human hypertension caused by mutations in WNK kinases. Science 293: 1107-1112
55. Xie J, Cha SK, An SW, Kuro O, Birnbaumer L, Huang CL (2012) Cardioprotection by Klotho through downregulation of TRPC6 channels in the mouse heart. Nat Commun 3: 1238
56. Yang CL, Angell J, Mitchell R, Ellison DH (2003) WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111: 1039-1045